Mucinex Sinus-Max Severe Congestion Relief
NDC 63824-201, Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride, tablet, coated, from Reckitt Benckiser LLC.
- Product NDC
- 63824-201
- Status
- Listed
- Labeler
- Reckitt Benckiser LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63824-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN325 mg/1
- GUAIFENESIN200 mg/1
- PHENYLEPHRINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63824-201-44 | 63824020144 | 4 POUCH in 1 CARTON (63824-201-44) / 2 TABLET, COATED in 1 POUCH (63824-201-72) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63824-201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63824-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63824-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.